Table 1 Baseline characteristics of the study population
n | Beta-Blockade (n = 37) | No Beta-Blockade (n = 69) | P-value | |
|---|---|---|---|---|
Age (years) | 106 | 73 (69.5–77.0) | 72 (68.0–76.0) | 0.3931 |
Gender: female | 106 | 22 (59.5%) | 40 (58.0%) | 0.8822 |
Body weight (kg) | 106 | 72 (66–80) | 78 (67–84) | 0.2511 |
Body height (cm) | 106 | 165 (160–170) | 169 (160–177) | 0.2451 |
BMI (kg/m2) | 106 | 26.1 (24.1–27.6) | 25.9 (23.8–28.6) | 0.9231 |
ASA-PS: | 106 | 0.2282 | ||
ASA I-II | 22 (59.9%) | 49 (71%) | ||
ASA III-IV | 15 (40.5%) | 20 (29.0%) | ||
Type of surgery: | 106 | 0.7872 | ||
Intracranial | 2 (5.4%) | 3 (4.3%) | ||
Thoracic/abdominal/pelvic | 10 (27.0%) | 15 (21.7%) | ||
Peripheral | 25 (67.6%) | 51 (73.9%) |